Vestibular schwannoma associated with neurofibromatosis type 2: Clinical course following stereotactic radiosurgery (vol 12, 996186, 2022)

被引：0
|
作者：
Kim, Junhyung [1 ]
Byeon, Yukyeng [1 ]
Song, Sang Woo [1 ]
Cho, Young Hyun [1 ]
Hong, Chang-Ki [1 ]
Hong, Seok Ho [1 ]
Kim, Jeong Hoon [1 ]
Lee, Do Heui [1 ]
Park, Ji Eun [2 ]
Kim, Ho Sung [2 ]
Kim, Young-Hoon [1 ]
机构：
[1] Univ Ulsan, Asan Med Ctr, Dept Neurol Surg, Coll Med, Seoul, South Korea
[2] Univ Ulsan, Asan Med Ctr, Dept Radiol, Coll Med, Seoul, South Korea
来源：
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
关键词：
neurofibromatosis type 2 (NF2); vestibular schwannoma (acoustic neuroma); stereotactic radiosurgery (SRS); tumor control; hearing preservation;
D O I：
10.3389/fonc.2022.1100854
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Neurofibromatosis type 2-associated meningiomas: an international multicenter study of outcomes after Gamma Knife stereotactic radiosurgery
    Mohammed, Nasser
    Hung, Yi-Chieh
    Xu, Zhiyuan
    Chytka, Tomas
    Liscak, Roman
    Tripathi, Manjul
    Arsanious, David
    Cifarelli, Christopher P.
    Caceres, Marco Perez
    Mathieu, David
    Speckter, Herwin
    Mehta, Gautam U.
    Lekovic, Gregory P.
    Sheehan, Jason P.
    JOURNAL OF NEUROSURGERY, 2022, 136 (01) : 109 - 114
  • [42] Stereotactic radiosurgery in the management of acoustic neuromas associated with neurofibromatosis Type 2 (Reprinted from J Neurosurg, vol 90, pg 815-822, 1999)
    Subach, Brian R.
    Kondziolka, Douglas
    Lunsford, L. Dade
    Bissonette, David J.
    Flickinger, John C.
    Maitz, Ann H.
    JOURNAL OF NEUROSURGERY, 2013, 119 : 59 - 66
  • [43] Factors Associated With New-Onset Seizures Following Stereotactic Radiosurgery for Newly Diagnosed Brain Metastases (vol 7, 101054, 2022)
    Lerner, Emily Claire
    Srinivasan, Ethan S.
    Broadwater, Gloria
    Haskell-Mendoza, Aden P.
    Vaios, Eugene J.
    Edwards, Ryan M.
    Wachsmuth, Lucas P.
    Huie, David
    Floyd, Scott R.
    Adamson, Justus D.
    Fecci, Peter E.
    ADVANCES IN RADIATION ONCOLOGY, 2023, 8 (02)
  • [44] Pretreatment Clinical Parameters Associated with Intracranial Progression Burden Following an Initial Stereotactic Radiosurgery Course in a Multi -Institutional Brain Metastases Cohort
    Huang, C. C.
    Qazi, J. J.
    Leng, J. X.
    Carpenter, D. J.
    Natarajan, B. D.
    Arshad, M.
    Schultz, O.
    Moravan, M. J., Jr.
    Mullikin, T. C.
    Reitman, Z. J.
    Kirkpatrick, J. P.
    Floyd, S. R.
    Chmura, S. J.
    Hong, J. C.
    Salama, J. K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E109 - E110
  • [45] Rationale and Design of BeatNF2 Trial: A Clinical Trial to Assess the Efficacy and Safety of Bevacizumab in Patients with Neurofibromatosis Type 2 Related Vestibular Schwannoma
    Fujii, Masazumi
    Kobayakawa, Masao
    Saito, Kiyoshi
    Inano, Akihiro
    Morita, Akio
    Hasegawa, Mitsuhiro
    Mukasa, Akitake
    Mitsuhara, Takafumi
    Goto, Takeo
    Yamaguchi, Shigeru
    Tamiya, Takashi
    Nakatomi, Hirofumi
    Oya, Soichi
    Takahashi, Fumiaki
    Sato, Taku
    Bakhit, Mudathir
    CURRENT ONCOLOGY, 2021, 28 (01) : 726 - 739
  • [46] Pretreatment clinical parameters associated with intracranial progression burden following an initial stereotactic radiosurgery course in a multi-institutional brain metastases cohort
    Huang, Christina C.
    Qazi, Jamiluddin
    Leng, Jim
    Carpenter, David James
    Natarajan, Brahma Darshni
    Arshad, Muzamil
    Schultz, Olivia
    Moravan, Michael James
    Mullikin, Trey Carlton
    Reitman, Zach
    Kirkpatrick, John P.
    Floyd, Scott R.
    Chmura, Steven J.
    Hong, Julian C.
    Salama, Joseph Kamel
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [47] Early phase clinical studies of AR-42, a histone deacetylase inhibitor, for neurofibromatosis type 2-associated vestibular schwannomas and meningiomas
    Welling, D. Bradley
    Collier, Katharine A.
    Burns, Sarah S.
    Oblinger, Janet L.
    Shu, Edina
    Miles-Markley, Beth A.
    Hofmeister, Craig C.
    Makary, Mina S.
    Slone, H. Wayne
    Blakeley, Jaishri O.
    Mansouri, S. Alireza
    Neff, Brian A.
    Jackler, Robert K.
    Mortazavi, Amir
    Chang, Long-Sheng
    LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY, 2021, 6 (05): : 1008 - 1019
  • [48] Multicenter, Prospective, Phase II and Biomarker Study of High-Dose Bevacizumab as Induction Therapy in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannoma (vol 45, pg 287, 2020)
    Plotkin, S. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06) : 656 - 656
  • [49] Reduction of sporadic and neurofibromatosis type 2-associated vestibular schwannoma growth in vitro and in vivo after treatment with the c-Jun N-terminal kinase inhibitor AS602801
    Dougherty, Mark C.
    Shibata, Seiji B.
    Clark, J. Jason
    Canady, Franklin J.
    Yates, Charles W.
    Hansen, Marlan R.
    JOURNAL OF NEUROSURGERY, 2023, 138 (04) : 962 - 971
  • [50] Trends in clinical characteristics and factors associated with initial prescription of SGLT2 inhibitors in Japanese patients with type 2 diabetes mellitus (vol 13, pg 606, 2022)
    Takahashi, Hiroshi
    Suganuma, Yuka
    Ohno, Takayuki
    Nishimura, Rimei
    DIABETOLOGY INTERNATIONAL, 2024, 15 (01) : 141 - 141
12345